We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$606M
AUM Growth
-$147M
(-20%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-25.06%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
657
New
70
Increased
165
Reduced
211
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$24.8M |
| 2 |
Constellation Brands
STZ
|
+$12.7M |
| 3 |
HCA Healthcare
HCA
|
+$12.2M |
| 4 |
Avery Dennison
AVY
|
+$12M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$15.3M |
| 2 |
Masco
MAS
|
+$14.6M |
| 3 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$14.6M |
| 4 |
Cintas
CTAS
|
+$14.5M |
| 5 |
United Parcel Service
UPS
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 16.62% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Financials | 10.34% |
| 4 | Communication Services | 8.36% |
| 5 | Materials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
The Mosaic Company
MOS
$7.19B
| $126K | 0.02% |
+4,832
| New | +$128K |
|
|
AGU
227
DELISTED
Agrium
AGU
| $126K | 0.02% |
1,400
| – | – |
|
228
iShares MSCI Turkey ETF
TUR
$201M
| $122K | 0.02% |
3,084
+443
| +17% | +$18.4K |
|
229
Edwards Lifesciences
EW
$49.4B
| $118K | 0.02% |
3,540
-72
| -2% | -$2.46K |
|
230
HP
HPQ
$26B
| $118K | 0.02% |
9,369
+1,831
| +24% | +$22.8K |
|
231
LyondellBasell Industries
LYB
$19.5B
| $115K | 0.02% |
1,547
+787
| +104% | +$65K |
|
232
Enbridge
ENB
$120B
| $114K | 0.02% |
2,702
-185
| -6% | -$7.54K |
|
|
MRO
233
DELISTED
Marathon Oil Corporation
MRO
| $112K | 0.02% |
+7,443
| New | +$98.4K |
|
234
Comcast
CMCSA
$87.3B
| $110K | 0.02% |
3,384
-3,288
| -49% | -$102K |
|
235
VanEck Vietnam ETF
VNM
$478M
| $110K | 0.02% |
7,528
-3,185
| -30% | -$45.8K |
|
236
JetBlue
JBLU
$2.16B
| $110K | 0.02% |
6,623
+4,200
| +173% | +$78K |
|
237
Accenture
ACN
$106B
| $108K | 0.02% |
954
+457
| +92% | +$53K |
|
238
Uranium Energy
UEC
$4.47B
| $105K | 0.02% |
119,500
-24,357
| -17% | -$20.2K |
|
|
WBA
239
DELISTED
Walgreens Boots Alliance
WBA
| $100K | 0.02% |
1,205
-866
| -42% | -$69.9K |
|
240
Invesco Pharmaceuticals ETF
PJP
$445M
| $98.1K | 0.02% |
1,549
+396
| +34% | +$24.9K |
|
241
TotalEnergies
TTE
$193B
| $91.9K | 0.02% |
+1,911
| New | +$91.5K |
|
|
MNK
242
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $88.1K | 0.01% |
1,450
+1,400
| +2,800% | +$85.6K |
|
243
VanEck Oil Services ETF
OIH
$1.97B
| $85.5K | 0.01% |
148
| – | – |
|
244
F5
FFIV
$22B
| $84.2K | 0.01% |
740
-15
| -2% | -$1.61K |
|
|
EMC
245
DELISTED
EMC CORPORATION
EMC
| $82.9K | 0.01% |
3,053
+1,449
| +90% | +$39.2K |
|
246
Broadcom
AVGO
$1.76T
| $82.7K | 0.01% |
5,320
+2,580
| +94% | +$39.3K |
|
|
NVO
247
Novo Nordisk
NVO
$228B
| $82K | 0.01% |
3,050
-62
| -2% | -$1.7K |
|
248
American International
AIG
$42.5B
| $80.3K | 0.01% |
1,519
-1,304
| -46% | -$72K |
|
249
WisdomTree India Earnings Fund ETF
EPI
$2.04B
| $80.1K | 0.01% |
+3,968
| New | +$77.7K |
|
250
McKesson
MCK
$104B
| $78.8K | 0.01% |
422
-8
| -2% | -$1.4K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2016 Portfolio in Review
As of Q2 2016, Exane Derivatives held 657 positions worth $606M, down 20% from $753M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives withdrew a net $152M in Q2 2016, closing 108 positions and reducing 211 holdings. Its most notable exit was Masco, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 17% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $20.8M.
- Exane Derivatives's largest Q2 2016 buy was UBS Group: 1,623,142 shares worth $20.8M.
- Exane Derivatives added most to Constellation Brands in Q2 2016, an estimated $12.7M increase.
- Exane Derivatives's biggest Q2 2016 reduction was Applied Materials, cutting an estimated $15.3M.
- Exane Derivatives fully exited Masco in Q2 2016, selling an estimated $14.6M.
- Exane Derivatives's ten largest holdings make up 26% of its $606M portfolio in Q2 2016.
- Exane Derivatives opened 70 new positions and closed 108 in Q2 2016.
- Exane Derivatives's portfolio value fell 20% quarter-over-quarter to $606M.
Based on Exane Derivatives's 13F filing for Q2 2016, filed 3 Aug 2016.